hotspot -WSS

hotspot

author：fashion 2025-09-07 17:26:49 - browse：28

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： JPM: CVS says Medicare Advantage patients are impacting profits

WSS

Ahead of JPM, here's who's profiting most in health care

HHS secretary Becerra pressed on Change HealthCare cyberattack

Male and female sex labels in research insufficient, scientists say

Readout Newsletter: Bristol, Sangamo, Gilead, and more

U.K. sequencing study surfaces new findings about tumor DNA

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

knowledge

hotspot

focus

Peter Hotez and the public health issue of online harassment

EPA limits use of carcinogenic gas for sterilizing medical devices

23andMe had bad news about my health. I wish a person had delivered it

EPA limits use of carcinogenic gas for sterilizing medical devices

Affirmative action in medical school literally saved lives

3 trends to watch in health tech's hiring outlook for 2024

State Dept. review finds Biden bears some blame for Afghanistan failures

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

First U.S. drug developed to treat liver disease MASH is approved

hotspot

As AI in medicine takes off, can 'human in the loop' prevent harm?

Why scientists need input from humanists on sensitive research

Federal weight loss drug coverage is 30 years out of date

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

EPA limits use of carcinogenic gas for sterilizing medical devices

White House finalizes ITC's import ban of latest Apple Watches

hotspot

focus

entertainment

hotspot